Koala retrovirus viral load and disease burden in distinct northern and southern koala populations by Sarker, Nishat et al.
1Scientific RepoRtS |          (2020) 10:263  | https://doi.org/10.1038/s41598-019-56546-0
www.nature.com/scientificreports
Koala retrovirus viral load and 
disease burden in distinct northern 
and southern koala populations
nishat Sarker1,5, Jessica fabijan2, Helen owen1, Jennifer Seddon 1, Greg Simmons1, 
natasha Speight 2, Jasmeet Kaler 3, Lucy Woolford2, Richard David emes 3,4, 
farhid Hemmatzadeh2, Darren J. trott2, Joanne Meers 1* & Rachael Eugenie tarlinton  3*
Koala retrovirus (KoRV) displays features of both an endogenous and exogenous virus and is linked 
to neoplasia and immunosuppression in koalas. This study explores the apparent differences in the 
nature and impact of KoRV infection between geographically and genetically separated “northern” and 
“southern” koala populations, by investigating the disease status, completeness of the KoRV genome 
and the proviral (DNA) and viral (RNA) loads of 71 northern and 97 southern koalas. All northern animals 
were positive for all KoRV genes (gag, pro-pol and env) in both DNA and RNA forms, whereas many 
southern animals were missing one or more KoRV genes. There was a significant relationship between 
the completeness of the KoRV genome and clinical status in this population. The proviral and viral loads 
of the northern population were significantly higher than those of the southern population (P < 0.0001), 
and many provirus-positive southern animals failed to express any detectable KoRV RNA. Across both 
populations there was a positive association between proviral load and neoplasia (p = 0.009). Potential 
reasons for the differences in the nature of KoRV infection between the two populations are discussed.
Koala retrovirus (KoRV) was first identified in tissues from a leukemic koala in 19881 and the full genome 
sequence was published in 20002. This is a unique endogenous retrovirus which is also capable of being transmit-
ted horizontally3. It is thought that KoRV plays a role in the pathogenesis of lymphoid neoplasia as well as causing 
immunosuppression, making koalas more susceptible to developing overt chlamydial disease4, which is a major 
threat to koala populations. However while there appears to be a strong association between KoRV infection and 
these diseases in koalas, there is currently little if any published data proving a causal link3,5,6.
Anecdotally, there are differences in disease prevalence between koala populations in northern and southern 
Australia. The prevalence of lymphoid neoplasia is high in northern koalas7 compared to southern koalas where 
lymphosarcoma has only recently been reported8. The prevalence of Chlamydia pecorum infection and overt 
chlamydial disease is also high in northern koalas in comparison to southern populations, with chlamydial dis-
ease reported in 52% of more than 20,000 koala admissions to wildlife hospitals in South East Queensland (SE 
QLD)9. In contrast, a recent necropsy study in South Australia (SA) reported only 21% of koalas with clinically 
overt disease10. Conversely, SA kocalas have a higher prevalence of oxalate nephrosis than QLD koalas, with 55% 
of SA koalas demonstrating renal dysfunction due to oxalate nephrosis11.
These differences in disease prevalence may be the result of genetic differences between northern southern 
koala populations12. Animals in the southern part of the range (the states of Victoria, South Australia [SA] and 
southern New South Wales [NSW]) have undergone a severe genetic bottleneck as a result of hunting pressures 
in the late 1800’s. These populations were restocked across much of their former population range from a very 
small number of island populations and as such fall into a separate genetic lineage compared to northern animals 
(Queensland [QLD], northern NSW)13. It is also conceivable that differences in KoRV parameters may be con-
tributing to the variation in disease prevalence between northern and southern populations.
The literature to date has indicated that koala populations in QLD exhibit 100% prevalence of KoRV, while a 
lower prevalence in southern koalas has been reported, with only 25% of wild Victorian koalas testing positive for 
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KoRV provirus14,15. These studies determined prevalence based on the presence of the KoRV proviral pol gene14,15. 
In contrast, the transcriptomic analysis of QLD and SA koalas submandibular lymph node tissue demonstrated 
KoRV transcripts in 100% of animals from both populations16, although 27.6% SA koalas were missing transcripts 
of pol or env or both of these genes and had only truncated transcripts of the gag gene16. Given these complex find-
ings, the role of KoRV in causing differences in disease occurrence between northern and southern populations 
is unlikely to be due only to proviral prevalence, and other viral characteristics must be explored. Investigating 
these characteristics in both populations may shed light on the pathogenesis of KoRV. It is possible that the full 
length of the proviral genome is present but not actively transcribed in southern animals, it is also possible that 
the provirus is fragmented or truncated and lacks the ability to transcribe accurately. The levels of KoRV proviral 
DNA load and viral RNA load also may influence disease expression in individual koalas. Viral RNA load has 
been shown to be a significant predictor for disease progression in other retroviral diseases such as HIV-117 and 
Feline immunodeficiency virus (FIV) infections18. With respect to KoRV, koalas with neoplasia exhibited signifi-
cantly higher levels of plasma viral RNA load compared to koalas without neoplasia19.
This study aimed to investigate characteristics of KoRV infection in koala populations in QLD (representative 
of the northern genotype) and SA (representative of the southern genotype). Results from a comprehensive suite 
of PCRs including conventional PCR, qPCR and RT-qPCR were analysed to obtain a greater understanding of 
KoRV provirus (DNA) and virus (RNA) in the two populations. The study aimed to: (i) investigate the complete-
ness of KoRV provirus and virus genomes, (ii) characterise differences in KoRV proviral load and viral load in 
the two populations and (iii) investigate associations between KoRV completeness, proviral load, viral load and 
disease.
Methods
Sample collection and preparation. Samples were collected from wild-rescued koalas euthanased for 
clinical reasons and submitted for post-mortem examinations from South East QLD (Greater Brisbane region) 
and SA (Mount Lofty Ranges). Clinically healthy northern captive koalas were also sourced from Sea World 
Paradise Country (SWPC), Australia. Blood was collected into EDTA tubes. Ethical approval for this study was 
granted by the University of Queensland (UQ) Animal Ethics Committee, permit number ANFRA/SVS/461/12 
and ANRFA/SVS/445/15, the Queensland Government Department of Environment and Heritage Protection 
permit number WISP11989112, University of Adelaide Animal Ethics Committee permit number S-2013-198 
and South Australian Government Department of Environment, Water and Natural Resources Scientific Research 
Permit Y26054. All methods were performed in accordance with the relevant guidelines and regulations.
DNA was extracted from 100 µl EDTA whole blood using Qiagen DNeasy Blood & Tissue Kit according to 
manufacturer’s (Qiagen) instructions and finally resuspended in 200 μl elution buffer provided in the kit. The 
extracted DNA concentration was measured using a Nanodrop spectrophotometer at 260 nm optical density to 
ensure DNA quantity and quality.
A 1–2 ml aliquot of blood was centrifuged at 3000 g for 5 mins and 200 μl of the plasma was removed and 
added to 300 μl of RNAlater stabilisation agent (Qiagen) within 1 hour of blood collection. Plasma samples were 
transported to UQ and stored at −80 °C until RNA extraction. RNA was extracted using Qiagen QIAmp Viral 
RNA mini kit with on-column Qiagen RNase free DNase steps. The extracted RNA samples were stored at −80 °C 
until required.
Clinical details and disease categories. Each koala’s sex, age determined by tooth wear, body condition 
score, medical history and rescue details were recorded at the time of sampling. A clinical and or post mortem 
examination was performed by the veterinarian or pathologist, if warranted, this included an abdominal ultra-
sound. Age was determined by dentition and the amount of wear on the upper premolar20. Tooth wear scores used 
to reflect age varied from 1–8 and koalas were grouped as follows: juvenile (TWC 1), young adult (TWC 2 or 3), 
adult (TWC 4, 5 or 6) and old (TWC 7 or 8). Body condition score of the koalas was also scored between 0–5 with 
≤2 being “poor”, 3 being “good” and ≥4 being “very good”.
Animals were grouped into five disease categories based on their clinical status and post mortem results. 
Animals free of any clinical signs were grouped as “healthy”, these included animals euthanased due to trau-
matic injury and live captive animals. Animals with any neoplastic changes were grouped as “neoplasia”. Animals 
with signs consistent with chlamydiosis such as cystitis (based on urine staining, rump wetness, clinical and 
post-mortem examination), conjunctivitis, paraovarian cysts, prostatitis, urethritis, keratitis and vaginitis21 were 
grouped as “chlamydiosis”. Animals with renal pathology consistent with oxalate nephrosis11 were grouped as 
“oxalate nephrosis”, and remaining clinical presentations were grouped as “miscellaneous”.
Determining presence and extent of KoRV genomic DNA and plasma RNA. Screening of DNA 
and RNA quality. The extracted DNA and RNA quality was initially assessed with an end point PCR of the 
housekeeping gene β-actin using published β-actin primers (Meers et al., 2014). DNA and RNA samples were 
amplified using Qiagen HotStartTaq Plus Master Mix kit and Qiagen OneStep RT-PCR kit respectively, following 
manufacturer instructions, with 35 cycles of amplification and an annealing temperature of 52 °C. Samples failing 
to amplify β-actin were excluded from further study.
Conventional PCR and conventional reverse transcriptase PCR. The presence of KoRV LTR, gag, pol and env pro-
virus and viral RNA were assessed using multiple primers covering different or overlapping sections of each gene 
(Table 1). The details of primers are depicted in Table 1 and the amplicon locations are indicated on the KoRV full 
genome shown in Fig. 1. Primers were designed using the full genome of KoRV-A (accession no. AF151794.2) as 
a reference sequence and NCBI Primer-BLAST, a primer designing tool.
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For the pol gene, a nested PCR using published internal primers15 was used on samples that failed to produce 
the expected 523 bp amplicon with primer pair P3 (pol long). PCR product (1.0 μl) from the pol long amplifica-
tion was used as a template for the nested PCR. Four different primer pairs were used to identify the presence of 
env gene. Proviral DNA and viral RNA was amplified using a Qiagen HotStartTaq Plus Master Mix kit and Qiagen 
OneStep RT-PCR kit, respectively following the manufacturer’s conditions with modification in annealing tem-
perature and 35 cycles of amplification. Each primer pairs annealing temperature is illustrated in Table 1.
All amplified PCR products were electrophoresed in a 1.5% agarose gel/Sodium Borate buffer and 5% Syber 
safe stain (ThermoFisher Scientific) and then visualized in Biorad Gel Documentation system. PCR reactions 
were directly purified with ExoSAP-IT (Thermo Fisher Scientific), following manufacturer’s instruction.
Amplicons from PCR purified products were Sanger sequenced using multiple internal primers or sequence 
specific primers by Big Dye Terminators by The Animal Genetics Laboratory, University of Queensland. 
Sequences were then subjected to BLAST analysis through the NCBI database to determine the percentage of 
homology.
Quantification of KoRV pol gene. Real-time PCR (qPCR) and reverse transcriptase qPCR (RT-qPCR) 
for the pol gene was used in addition to the conventional PCRs in order to increase the sensitivity of screening 
for KoRV provirus DNA and viral RNA, respectively and to determine the proviral load (KoRV DNA copies/103 
β-actin copies) and viral load (KoRV RNA copies/ml plasma). Only the pol gene was analysed with this method-
ology due to the conserved nature of the gene and its widespread use for KoRV diagnosis. The previously pub-
lished real time PCR primers (P5 in Table 1; Fig. 1) and probe for KoRV pol and the housekeeping gene, β-actin 
were used for the multiplex PCR reaction19,22. The samples were run in triplicate on a BioRad CFX 96 system. 
Serially diluted DNA and RNA standards were used in each run to determine the copy number in each sample.
For the proviral DNA qPCR, a Taqman gene expression master mix (Applied biosystem) was used with the 
following composition: Taqman master mix 12.5 μl, β-actin probe 5 μM 1.25 μl, MGB pol probe 5 μM 1.25 μl, 
MGB pol primers forward and reverse 10 μM 2.5 μl, β-actin primers forward and reverse 10 μM 2.5 μl and sample 
DNA 5 μl. Cycling conditions were as per manufacturer’s instructions. If both β-actin and pol showed a CT value 
of at least 35 then the samples were considered KoRV-positive, β-actin positive pol negative samples were consid-
ered KoRV-negative. If both β-actin and pol were negative, then the sample was removed from further analysis.
Reaction mix for the RT-qPCR consisted of 1x reaction mix, 0.05 U/µl of SuperScript® III RT/Platinum® 
Taq Mix (SuperScript® III One-Step RT-PCR System with Platinum® Taq DNA Polymerase, Invitrogen), 10 µM 
of each primers (forward and reverse), 10 µM of probe, 5.5 µl of ultrapure water, and 5 µl of template. Cycling 
conditions were: reverse transcription at 50 °C for 30 min, Superscript platinum taq activation at 95 °C for 2 min, 
followed by 45 cycles of denaturation at 95 °C for 15 sec and annealing at 60 °C for 30 sec.
Statistical analysis. Descriptive statistics were explored using Stata 14 (Mann-Whitney U for continu-
ous variables or Chi squared for categorical variables) (Statacorp, USA) to compare proviral load and viral load 
between QLD and SA koalas and investigate their association with age, sex, body weight and body condition 
score and disease category. As proviral load and viral load were non-parametrically distributed, values were trans-
formed to log scales for model building. After univariable analysis, a multivariable linear regression model was 
built in STATA 14 (Statacorp, USA) with the input variables of: location or origin (SA, QLD), sex (Male, Female), 
age group (juvenile, young adult, adult and old), Body condition score (poor, good, and very good), Disease 
category (healthy, neoplasia, chlamydiosis, oxalate nephrosis and miscellaneous) and the outcome parameter of 
proviral load. P-values of <=0.05 was considered significant.
Results
Epidemiological characteristics of collected samples. Overall, 176 koalas from QLD (n = 71) and 
SA (n = 105) were sampled in this study, part of the Koala retrovirus pathogenesis project, conducted between 
2014 and 2017. Not all koala samples were available for all assays because of limitations on sample quantity or the 
quality of extracted DNA or RNA. A total of 155 animals had complete data for all parameters in the model and 
were included in the model.
Coded region Forward Reverse
Annealing 
temperature (°C) Reference
P1 LTR ACCCCGGACTTATGCAAACA CTCACCCTGTCCCATTCTGG 52 this study
P2 gag ATGGGACAGGGTGAGTCG TCACCCAGGGTCAGGACATT 55 this study
P3 pol CCTTGGACCACCAAGAGACTTTTGA TCAAATCTTGGACTGGCCGA 50 3
P4 pol TCATGGCTCCAACTCTTTCC TACCAGAATCCCCAAATCCA 50 15
P5 pol TTGGAGGAGGAATACCGATTACAC GCCAGTCCCATACCTGCCTT 60 19
P6 env TCCTGGGAACTGGAAAAGAC GGGTTCCCCAAGTGATCTG 52 4
P7 env TCACCAACCCATGACTCTCA AGGACTCGAGACCGGCTA 52 this study
P8 env GGTCCATGCTTCTCATCTCA AGATGGAGTACTAGGGGCCG 52 41
P9 env GCCCTCGGCCCTCCTTATTA GGCAATCTGGAGGCTAGTCAA 52 this study
Probe pol 5′-FAM-TCGACCCGTCATGGC-MGBNFQ-3′ 19
Table 1. PCR primers and probe used in this study.
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The summary of demographic characteristics of the collected samples are described in Table 2. In general, 
koalas collected from QLD were older (Chi squared P = 0.0007), lighter weight (Mann-Whitney U P < 0.001) and 
had a lower body condition score (Chi squared P < 0.001). There were no differences in the sex ratio between the 
two populations. Large differences in disease prevalence were observed between the populations (Chi Squared 
P = 0.003); a higher proportion of QLD koalas presented with neoplasia and chlamydiosis than SA koalas, and no 
QLD koalas had oxalate nephrosis (Table 2). Some koalas presented with multiple conditions (eg. neoplasia and 
chlamydiosis). The complete data for each koala are presented in Supplementary Table 1.
Status of KoRV in QLD and SA koalas. Both conventional and qPCR techniques were applied to deter-
mine the presence of various KoRV genes in the QLD and SA koalas. For detection of proviral DNA there were 
eight conventional PCRs and one qPCR (pol gene only), and for viral RNA detection there were seven RT-PCRs 
and one RT-qPCR (pol gene only). All QLD koalas (n = 71) were positive in all PCRs for both KoRV proviral 
DNA and viral RNA. In the SA koalas, there were varying levels of positivity in the KoRV proviral DNA conven-
tional PCRs, ranging from 41% (40/97) in the env P9 PCR to 94% in the env P7 PCR (Table 3). All but one SA 
koala were provirus positive in the qPCR (P5), i.e. 96/97 (99%). When the PCRs (including qPCR) were grouped 
by KoRV gene (and classing LTR as a gene), 77/97 koalas were positive for all 4 genes, 19/97 were positive for only 
1, 2 or 3 genes and one koala was not positive for any gene (detailed in Supplementary Table 2).
Only 41 plasma RNA samples were available from SA koalas. In general, the level of positivity in conventional 
RT-PCRs was low, ranging from only 12% (5/41) for P2, P3, P8 and P9 RT-PCRs to 24% (10/41) for P6 RT-PCR 
(Table 3). On the RT-qPCR, 51% (21/41) of SA koalas were positive. When the RT-PCRs (including RT-qPCR) 
were grouped into genes, only 5/41 (12%) koalas were positive for all genes, 17/41 (42%) were positive for 1 
Figure 1. Location of target sequence for the conventional PCR and qPCR assays used in the study. PCR 
products (P) 1, 2, 6, 7, 8 & 9 are conventional PCR, P3 & P4 form a nested PCR; P5 is qPCR. PCR product 
coordinates are with respect to full KoRV genome sequence (8431 bp) (Genbank accession: AF151794).
Variablea QLD SA Statistical test
Sex
Female 31 (41%) 40 (40%)
Male 44 (59%) 61 (60%)
Total 75 (100%) 101 (100%) Chi Squared Not Significant
Age Group
Juvenile 5 (7%) 6 (6%)
Young Adult 15 (21%) 44 (46%)
Adult 44 (63%) 45 (47%)
Old 6 (9%) 0 (0%)
Total 70 (100%) 95 (100%) Chi Squared (P = 0.007)
Mean Weightc
5.5 kg 7.7 kg Mann Whitney U (P < 0.0001)
Body Condition Score
Poor 40 (58%) 22 (22%)
Good 18 (26%) 42 (42%)
Very good 11 (16%) 36 (36%)
Total 69 (100%) 100 (100%) Chi Squared (P < 0.001)
Clinical Statusb
Chlamydiosis 35 (50%) 42 (40%)
Neoplasia 9 (13%) 4 (4%)
Oxalate nephrosis 0 (0%) 23 (22%)
Miscellaneous 8 (11%) 11 (10%)
Healthy 22 (31%) 29 (28%) Chi Squared (P = 0.003)
Totala 71 105
Table 2. Demographic data summary for animals from the two populations. aNot all animals had complete 
data sets available. bSome animals had more than one disease state so the % add up to more than 100. QLD: 
Queensland; SA: South Australia. cUntransformed variables.
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or 2 genes, and 19/41 (46%) were negative for all genes. Complete results for each SA animal are presented in 
Supplementary Table 2.
Completeness of KoRV provirus and gene transcription versus disease syndromes in SA koalas. 
The PCR status of proviral DNA of SA koalas (positive for all genes or not) exhibited a significant relationship 
with disease category (chi-square, P = 0.0014). As shown in Table 4, all koalas with neoplasia were positive for all 
proviral KoRV genes and were transcribing some or all genes, whereas no healthy or oxalate nephrosis animals 
were transcribing all viral genes. Animals with chlamydiosis or miscellaneous conditions fell in between these 
extremes.
Proviral and Viral loads of QLD and SA koalas. The median proviral load in QLD koalas was 5.47 × 104 
KoRV DNA copies/103 β-actin copies. The median proviral load of SA koalas was 2.71 × 103 KoRV DNA cop-
ies/103 β-actin copies, which was significantly lower than QLD koalas (two tailed Man Whitney U, P < 0.0001) 
(Fig. 2A).
Similarly, all QLD koalas had high plasma viral loads. The median viral load of QLD koalas was 4.07 × 108 
KoRV RNA copies/ml. Only 51.2% (21/41) SA koalas had detectable viral pol gene RNA and the median viral 
load was 1.89 × 105 KoRV RNA copies/ml plasma. The viral load in SA koalas was significantly lower than those 
of QLD koalas (two tailed Man Whitney U, P < 0.0001) (Fig. 2B). Individual animal proviral and viral loads are 
presented in Supplementary Table 2.
There was a significant correlation between proviral load and viral load (R2 = 0.4486, P value < 0.0001) across 
all animals, shown in Fig. 3.
The median proviral load was significantly higher (two tailed Mann Whitney-U, P value = 0.009) in SA ani-
mals that were actively transcribing virus (viral RNA positive) compared to koalas that were viral RNA negative 
(Fig. 4).
Association between KoRV provirus and population characteristics. As there were low numbers of 
SA koalas positive for viral RNA and viral load, statistical analysis of koala population characteristics and disease 
were performed with proviral loads only. No significant association was found between koalas’ sex (correlation) 
Gene: Primer Pair Provirus DNA Viral RNA
Conventional PCR and RT-PCR
LTR: P1 89/97 (92%)a N.D.
Gag: P2 79/97 (81%) 5/41 (12%)
Pol: P3 37/97 (38%) 5/41 (12%)
Pol nested: P4 40/77b (52%) 1/36b (3%)
Total pol positivec 77/97 (79%) 6/41 (15%)
Env: P6 88/97 (91%) 10/41 (24%)
Env: P7 91/97 (94%) 9/41 (22%)
Env: P8 40/97 (41%) 5/41 (12%)
Env: P9 63/97 (65%) 5/41 (12%)
Total env positived 94/97 (97%) 10/41 (24%)
qPCR & RT-qPCR Pol: P5 96/97 (99%) 21/41 (51%)
Table 3. Rate of PCR positivity for multiple conventional and qPCR reactions for KoRV proviral (DNA) and 
viral (RNA) in SA koala samples. aNumber positive/number tested (percent positive). b37 and 5 positive samples 
in P3 PCR and RT-PCR, respectively, were not tested in P4. cAn animal was scored positive if it was PCR-
positive on either of the pol primer pairs (P3 or P4). dAn animal was scored positive if it was PCR-positive on 
any of the four env primer pairs (P6, P7, P8 or P9).
Proviral DNA (total n = 97) Viral RNA (total n = 41)
PCR-positive 
all genes*
PCR-positive in some 
but not all genes
PCR-negative 
all genes
PCR-positive 
all genes
PCR-positive in  
some but not all genes
PCR-negative 
all genes
Neoplasia  
(N = 5, DNA, 4, RNA) 5 (100%) 0 (0%) 0 (0%) 3 (75%) 1 (25%) 0 (0%)
Chlamydiosis
(N = 34, DNA 17, RNA) 13 (38%) 21 (62%) 0 (0%) 2 (12%) 7 (41%) 8 (47%)
Oxalate nephrosis
(N = 23, DNA, 9 RNA) 6 (26%) 16 (70%) 1 (4%) 0 (0%) 2 (22%) 7 (78%)
Miscellaneous
(N = 15, DNA, 8 RNA) 10 (66%) 5 (33%) 0 (0%) 1 (13%) 4 (50%) 3 (38%)
Healthy
(N = 26, DNA, N = 8 RNA) 6 (23%) 20 (77%) 0 (0%) 0 (0%) 3 (38%) 5 (62%)
Table 4. Proviral DNA and viral RNA gene positivity of SA koalas in each disease category. Some koalas appear 
in more than one disease category. *LTR is classed as a gene in this table.
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or body weight (Mann Whitney U) and proviral load. There was an association between lower body condition 
score and proviral load (Kruskal Wallis test, P < 0.0001, Dunns post hoc showed koalas with a “poor” body con-
dition score had significantly higher median proviral loads than koalas with a “good” and “very good” body 
condition score (Fig. 5A). Similarly, there was an association between increasing proviral load and age (Kruskal 
Wallis P = 0.02, Dunns post hoc), with “adult and old” koalas having significantly higher median loads than 
“young adults” (Fig. 5B).
Association of KoRV proviral loads with disease category. There were significant associations 
between median proviral load and some disease categories when each disease category was analysed against 
the median proviral load of the other categories combined (two tailed Mann Whitney U). Koalas with neoplasia 
(P = 0.009) and miscellaneous diseases (P = 0.0071) had significantly higher proviral loads, whereas animals with 
oxalate nephrosis (P < 0.0001) and healthy animals (P < 0.0001) had significantly lower proviral loads (Fig. 6). 
The proviral loads of animals with chlamydiosis were not significantly different to other disease categories.
Multivariate modelling. Variables that showed a significant association with proviral load in the multi-
variate model were area of origin (QLD vs SA) and disease category (neoplasia), where samples from QLD had 
significantly higher proviral loads compared to samples from SA and samples that had neoplasia had significantly 
higher proviral loads compared to healthy samples. These effects were significant after controlling for effect of age, 
sex, body weight and body condition score of the koalas. The overall model explained 54% of total variability in 
proviral load in the study. Model results are presented in Table 5.
Figure 2. Comparison of (A) proviral DNA and (B) viral RNA loads between QLD (n = 71) and SA (DNA, 
n = 96; RNA, n = 21) koalas, evaluated using non-parametric Mann-Whitney U test. All resultant copy number 
values have been log10 transformed. Each dot denotes an individual’s KoRV load, Median line and interquartile 
range displayed. Y-axis shows individual koala values (log transformed) for (A) KoRV DNA copies/103 β-actin 
copies and (B) KoRV RNA copies/ml plasma. X-axis is the location of the koala population. The proviral DNA 
and viral RNA load of KoRV was significantly (p < 0.0001) different between the populations.
Figure 3. Correlation between pol gene proviral and viral loads of 91 QLD and SA koalas. X-axis shows 
individual koala values (log 10 transformed) of KoRV DNA copies/103 β-actin copies; Y-axis shows (log 10 
transformed) KoRV RNA copies/ml plasma of those koalas. SA animals are shown as squares and QLD animals 
as dots.
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Discussion
Koala populations are declining at a significant rate in most parts of Australia, particularly in Queensland, 
and koala retrovirus (KoRV) is likely to be contributing to the decline by inducing infectious diseases, such as 
chlamydiosis and neoplasia19,21. This study characterised the differences in extent of KoRV provirus (DNA) and 
viral expression (RNA) in QLD and SA koalas and investigated associations with disease.
All QLD koalas in the study were 100% positive for KoRV provirus pol DNA and viral pol RNA as has been 
reported in multiple studies15,19. In contrast, while 99% (n = 96/97) of SA koalas were positive for KoRV proviral 
DNA, only 51.2% (n = 21/41) had detectable viral RNA, based on qPCR and RT-qPCR of the pol gene, respec-
tively. The high KoRV provirus prevalence of SA animals in the Mount Lofty Ranges was unexpected, as a recent 
study reported the provirus prevalence in wild-caught koalas in the same location to be 65% (49/75), detected 
by qPCR23. The same study and a previous study14 reported proviral prevalence of 42% and 15%, respectively, 
in wild-caught koalas on Kangaroo Island, SA. The higher proviral prevalence in SA koalas in the current study 
may have been influenced by the fact that the animals were rescued because of illness or injury, whereas the other 
studies were based on wild-caught animals that were predominantly healthy.
In line with data from the SA population generated by Illumina sequencing16 many SA animals did not test 
positive for all proviral gene segments of KoRV like their QLD counterparts. More interestingly even fewer of 
these animals had detectable RNA transcription for gag, pol or env genes. The absence of viral RNA in many of 
the proviral positive SA animals might be the result of a latent KoRV infection, where proviral DNA has been 
integrated into the host genome but gene transcription has been suppressed as occurs in feline leukemia virus 
infected cats24–28. It is also possible that these animals may not have full length viral loci present, resulting in 
inefficient viral transcription or they may have sequence variants of the virus that are not being detected by PCR 
assays. Full viral locus sequencing at DNA and RNA levels is required to resolve this, however this is not easy to 
achieve for retroviruses with the PCR based methods used in this study.
Figure 4. Comparison of KoRV pol proviral level between SA koalas that were RT-qPCR positive (20 animals) 
or negative (21 animals) for KoRV viral RNA in plasma. Median line and interquartile ranged displayed. Y-axis 
shows individual koala values (log transformed) of KoRV DNA copies/103 β-actin copies.
Figure 5. Comparison of KoRV pol proviral level and (A) body condition score (BCS) (61 poor, 55 good, 44 
very good) and B) age (11 juvenile, 56 young adult and 90 adult and aged) of QLD and SA koalas. Y-axis shows 
individual koala values of log 10 KoRV DNA copies/103 β-actin copies. Median line and interquartile range 
displayed.
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The variable prevalence of proviral genes and the absence of viral RNA in a large proportion of the SA koalas 
allows investigation of causal links between these KoRV parameters and disease, which is not possible in the 
100% KoRV positive QLD koalas. In the SA animals, the presence of potentially full length provirus (all proviral 
genes) was associated with both transcription of viral RNA and disease category, where a positive association with 
neoplasia and a negative association with oxalate nephrosis (which is thought to be a genetic disorder unrelated 
to KoRV) were observed. The median KoRV proviral and viral loads in QLD koalas were significantly higher 
than those of SA koalas, which is in line with previous publications on proviral load15,23. In addition, a significant 
correlation between an individual’s proviral and viral loads were observed.
There are a number of potential explanations for the regional variation in viral loads between these two popu-
lations. Previous studies of genetic diversity have demonstrated genetic divergence between northern and south-
ern koala populations12,29,30. The presence of the probable genetic disorder oxalate nephrosis solely in the SA 
population in this study also points strongly to genetic segregation between the QLD and SA animals31. It is 
possible that the genes encoding the known host receptors for KoRV infection (Pit1 and THTR1) are divergent 
between the two populations, analogous to the genetic resistance against murine leukaemia virus strains that 
occurs in some mouse strains32. Such differences in host receptor genes between QLD and SA koalas would 
potentially result in a reduced level of KoRV replication in the SA population. It is also possible that mutations 
in other host genes important in retroviral replication differ between the two populations, resulting in restricted 
KoRV replication in the SA animals.
Immune responses to the virus have been shown to vary between these populations in other studies33,34. QLD 
animals may become immunologically tolerant to the virus through in-utero expression of endogenous viral 
genes, resulting in an inability to respond effectively to infection by exogenous virus in later life, leading to high 
viral loads. However, studies investigating KoRV antibodies in QLD koalas have given mixed results, with some 
Figure 6. Comparison of KoRV pol proviral load and disease category of 48 healthy, 17 oxalate nephrosis, 18 
miscellaneous, 68 chlamydiosis, 14 neoplasia QLD and SA koalas. Y-axis shows individual koala values of log 10 
KoRV DNA copies/103 β-actin copies. Median line and interquartile range displayed.
Variable Name Coefficient
Standard
Error p-value 95% CI
Intercept 5.919 0.478 4.974 to 6.865
Area: (QLD V SA) −1.173 0.136 <0.001 −1.442 to 0.904
Sex (F v M) −0.177 0.114 0.124 −0.403 to 0.049
Body Weight −0.0006 0.0019 0.746 −0.004 to 0.003
Age (Vs old)
adult −0.1254584 0.1892652 0.508 −0.4995999 to 0.2486831
young −0.0713457 0.3335621 0.831 −0.730735 to 0.5880436
juvenile −0.015101 0.0653133 0.817 −0.1442131 to 0.1140111
Body condition score (Vs good)
Poor 0.1712522 0.149053 0.253 −0.1233973 to 0.4659017
Very good 0.1385926 0.1494622 0.355 −0.156866 to 0.4340512
Disease Status (Vs healthy)
Chlamydiosis 0.0997492 0.1455689 0.494 −0.188013 to 0.3875114
Neoplasia 0.6796565 0.2098902 0.001 0.2647431 to 1.09457
Oxalate nephrosis −0.1109544 0.2042469 0.588 −0.5147119 to 0.2928032
Miscellaneous 0.1632565 0.1981873 0.411 −0.2285224 to 0.5550354
Table 5. Multivariate modelling outcomes, P values that were significant are in bold.
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showing no detectable antibodies35 while others reported that Qld koalas in fact produced antibodies to multiple 
KoRV antigens34. In contrast, it has been suggested that SA animals might be infected only with an exogenous 
virus and as such are able to mount an immune response to the virus, as shown in a study in which both KoRV 
positive and negative koalas developed KoRV antibodies upon vaccination34.
Conversely, it is also possible that SA koalas might possess partial replication-defective endogenous KoRV 
sequences, which provide protection against exogenous virus replication. This is analogous to some endogenous 
Avian leucosis viruses36, Jaagsietke sheep retrovirus37 and Murine Leukaemia viruses32, in which endogenous env 
gene is expressed and defective envelope proteins are produced in some individuals. The env proteins effectively 
‘blockade’ the retrovirus receptor, thereby preventing infection from exogenous viruses. This might explain the 
differences in proviral and viral loads between the two populations.
It was thought until recently that southern animals only possessed KoRV-A14,23 and not other variants of the 
virus and this might be a potential explanation for the reduced disease burden in southern animals. However 
our recent work has shown that South Australian animals do in fact have multiple variants of KoRV (including 
KoRV-B)16,38. The previous lack of detection of non-KoRV-A variants in southern populations is likely due to the 
use of relatively insensitive end point PCR for detection, together with the overall low proviral and viral loads in 
these populations.
The association between KoRV proviral loads and disease was explored at both a univariate and multivariate 
level. In univariate analysis koalas with a poor body condition score and older animals had higher proviral loads. 
The association between BCS and proviral load may be analogous to the wasting syndromes reported in associ-
ation with other retroviruses such as HIV39. An association with age and viral load (though not a linear one) has 
been reported previously19 and this study partially confirms that. High KoRV proviral load was also associated 
with neoplasia, and “miscellaneous” diseases whereas healthy animals and those with the genetic disorder oxalate 
nephrosis had lower viral loads in univariate analysis. However when multivariate analysis was applied to control 
for multiple conditions and factors in individual animals the only parameters that remained firmly associated 
with proviral load were location of animal (with SA animals having lower proviral loads than QLD animals) 
and disease status (animals with neoplasia having higher proviral loads than healthy animals). The lack of a link 
between chlamydiosis and proviral load can partly be explained by the fact that most of the animals with neo-
plasia also had concurrent chlamydial disease. This study therefore supports earlier observations19 of a firm link 
between KoRV viral load and neoplasia but does not find a statistically significant association between proviral 
load and chlamydial disease as reported by14.
The link between KoRV loads and disease raises the issue of whether the association is causative or a con-
sequence of disease. It is possible that the immunosuppression induced by chronic disease allows a subsequent 
escape of KoRV from immune control and increase in viral load and detection rates, i.e. that increased KoRV load 
is a consequence rather than a trigger of disease. However a recent longitudinal study of a large number of wild 
koalas40 indicates that KoRV viral load is relatively stable over time in an individual regardless of disease state and 
that high viral loads precede the development of clinical chlamydial disease rather than follow it.
This comparative population study provides some intriguing insights into KoRV and disease dynamics in 
these two genetically and geographically distinct koala populations. The QLD animals as reported in many studies 
are universally 100% positive for (presumably full length) KoRV with all gene segments detected. The SA animals 
on the other hand have lower KoRV proviral loads and not all genes are detectable in many animals. There is a 
strong link in both populations between proviral load and the viral load. The SA animals that did not possess all 
proviral genes were less likely to have detectable viral RNA and less likely to display KoRV associated disease. 
The underlying reasons for these population level differences in KoRV and disease are still not clear and require 
careful further work to untangle whether this is due to genetic variation in the animals (eg. the virus receptors), 
the presence or absence of endogenous versus exogenous forms of the virus (and therefore the animal’s ability to 
control viral replication immunologically) or blockade of KoRV infection by replication defective variants present 
only in the SA population.
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